Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 2.2 Certificate of Merger As Filed with the Delaware Secretary of State Effective October 28, 2022
- 3.1 Amended and Restated Certificate of Incorporation of Coeptis Therapeutics Holdings, Inc.
- 3.3 Amended and Restated Bylaws of Coeptis Therapeutics Holdings, Inc.
- 4.1 2022 Equity Incentive Plan
- 21.1 Subsidiaries of Coeptis Therapeutics Holdings, Inc.
- 23.1 Consent of Independent Registered Public Accounting Firm
- 99.1 Audited Financial Statements of Coeptis Therapeutics, Inc.
- 99.2 Unaudited Pro Forma Condensed Combined Financial Statements for the Year Ended December 31, 2021 and As of and for the Six Months Ended June 30, 2022
- 99.3 Coeptis Therapeutics Holdings Inc. Presentation
- 99.4 Coeptis Therapeutics Inc. Press Release Dated October 31, 2022
- 99.5 Coeptis Therapeutics Holdings Inc. Press Release Dated November 2, 2022
- Download Excel data file
- View Excel data file
COEPW similar filings
- 17 May 23 Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
- 31 Jan 23 Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development Program
- 29 Dec 22 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 3 Nov 22 Index to Financial Statements
- 26 Oct 22 Submission of Matters to a Vote of Security Holders
- 6 Jul 22 Regulation FD Disclosure
- 20 May 22 Entry into a Material Definitive Agreement
Filing view
External links